CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas will join the panel, "How the Other Half Lives: What's Happening in Venture and Why it Matters" at the BIO CEO Investor conference.
News | 02. 11. 2013
Art Pappas will join the panel, "How the Other Half Lives: What's Happening in Venture and Why it Matters" at the BIO CEO Investor conference.
